RT Journal Article
SR Electronic
T1 High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003804
DO 10.1136/jitc-2021-003804
VO 10
IS 2
A1 Clara, Joseph Andrew
A1 Levy, Emily R
A1 Reger, Robert
A1 Barisic, Stefan
A1 Chen, Long
A1 Cherkasova, Elena
A1 Chakraborty, Mala
A1 Allan, David S J
A1 Childs, Richard
YR 2022
UL http://jitc.bmj.com/content/10/2/e003804.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.